179 related articles for article (PubMed ID: 9371360)
1. Studies of the killing kinetics of benzylpenicillin, cefuroxime, azithromycin, and sparfloxacin on bacteria in the postantibiotic phase.
Odenholt I; Löwdin E; Cars O
Antimicrob Agents Chemother; 1997 Nov; 41(11):2522-6. PubMed ID: 9371360
[TBL] [Abstract][Full Text] [Related]
2. Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis.
Davies TA; Kelly LM; Hoellman DB; Ednie LM; Clark CL; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2000 Mar; 44(3):633-9. PubMed ID: 10681330
[TBL] [Abstract][Full Text] [Related]
3. Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin.
Odenholt-Tornqvist I; Löwdin E; Cars O
Antimicrob Agents Chemother; 1992 Sep; 36(9):1852-8. PubMed ID: 1329631
[TBL] [Abstract][Full Text] [Related]
4. Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens.
Odenholt-Tornqvist I; Löwdin E; Cars O
Antimicrob Agents Chemother; 1995 Jan; 39(1):221-6. PubMed ID: 7695310
[TBL] [Abstract][Full Text] [Related]
5. Effects of benzylpenicillin on Streptococcus pyogenes during the postantibiotic phase in vitro.
Odenholt I; Holm SE; Cars O
J Antimicrob Chemother; 1989 Aug; 24(2):147-56. PubMed ID: 2676938
[TBL] [Abstract][Full Text] [Related]
6. Bactericidal kinetics and postantibiotic effect of sparfloxacin against selected species of respiratory pathogens.
Speciale A; Blandino G; Nicolosi VM; Siracusa V; Caccamo F
J Chemother; 1995 Dec; 7(6):530-4. PubMed ID: 8667038
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of beta-lactam antibiotics. Studies on the paradoxical and postantibiotic effects in vitro and in an animal model.
Odenholt-Tornqvist I
Scand J Infect Dis Suppl; 1989; 58():1-55. PubMed ID: 2499924
[TBL] [Abstract][Full Text] [Related]
8. A new method to determine postantibiotic effect and effects of subinhibitory antibiotic concentrations.
Löwdin E; Odenholt-Tornqvist I; Bengtsson S; Cars O
Antimicrob Agents Chemother; 1993 Oct; 37(10):2200-5. PubMed ID: 8257145
[TBL] [Abstract][Full Text] [Related]
9. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1994 Sep; 38(9):2065-72. PubMed ID: 7811020
[TBL] [Abstract][Full Text] [Related]
10. Postantibiotic effect, and postantibiotic effect of subinhibitory concentrations, of sparfloxacin on gram-negative bacteria.
Odenholt-Tornqvist I; Bengtsson S
Chemotherapy; 1994; 40(1):30-6. PubMed ID: 8306813
[TBL] [Abstract][Full Text] [Related]
11. Postantibiotic effect and postantibiotic sub-mic effect of dirithromycin and erythromycin against respiratory tract pathogenic bacteria.
Dornbusch K; Olofsson C; Holm S
APMIS; 1999 May; 107(5):505-13. PubMed ID: 10335955
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of bactericidal activities, postantibiotic effects, and effects of bacterial virulence of penicillin G and six macrolides against Streptococcus pneumoniae.
Fuursted K; Knudsen JD; Petersen MB; Poulsen RL; Rehm D
Antimicrob Agents Chemother; 1997 Apr; 41(4):781-4. PubMed ID: 9087489
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic effects of subinhibitory concentrations of beta-lactam antibiotics in vitro.
Odenholt-Tornqvist I; Löwdin E; Cars O
Antimicrob Agents Chemother; 1991 Sep; 35(9):1834-9. PubMed ID: 1952854
[TBL] [Abstract][Full Text] [Related]
14. In vitro comparative dynamics of modified-release clarithromycin and of azithromycin.
Scaglione F; Demartini G; Dugnani S; Fraschini F
Chemotherapy; 2000; 46(5):342-52. PubMed ID: 10965100
[TBL] [Abstract][Full Text] [Related]
15. Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents.
Credito KL; Lin G; Pankuch GA; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2001 Jan; 45(1):67-72. PubMed ID: 11120946
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics of telithromycin In vitro against respiratory tract pathogens.
Odenholt I; Löwdin E; Cars O
Antimicrob Agents Chemother; 2001 Jan; 45(1):23-9. PubMed ID: 11120939
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model.
Löwdin E; Odenholt I; Bengtsson S; Cars O
Antimicrob Agents Chemother; 1996 Nov; 40(11):2478-82. PubMed ID: 8913449
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal properties of moxifloxacin and post-antibiotic effect.
Boswell FJ; Andrews JM; Wise R; Dalhoff A
J Antimicrob Chemother; 1999 May; 43 Suppl B():43-9. PubMed ID: 10382875
[TBL] [Abstract][Full Text] [Related]
19. Effects of supra- and sub-MIC benzylpenicillin concentrations on group A beta-haemolytic streptococci during the postantibiotic phase in vivo.
Odenholt I; Holm SE; Cars O
J Antimicrob Chemother; 1990 Aug; 26(2):193-201. PubMed ID: 2211456
[TBL] [Abstract][Full Text] [Related]
20. Impact of carbon dioxide on the susceptibility of key respiratory tract pathogens to telithromycin and azithromycin.
Bouchillon SK; Johnson JL; Hoban DJ; Stevens TM; Johnson BM
J Antimicrob Chemother; 2005 Jul; 56(1):224-7. PubMed ID: 15890718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
